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Chronic ER stress is emerging as a trigger that imbalances a number of systemic and arterial-wall factors and promote atheroscle-
rosis. Macrophage apoptosis within advanced atherosclerotic lesions is also known to increase the risk of atherothrombotic disease.
We hypothesize that glucolipotoxicity might mediate monocyte activation and apoptosis through ER stress. Therefore, the aims of
this study are (a) to investigate whether glucolipotoxicity could impose ER stress and apoptosis in THP-1 human monocytes and
(b) to investigate whether 4-Phenyl butyric acid (PBA), a chemical chaperone could resist the glucolipotoxicity-induced ER stress
and apoptosis. Cells subjected to either glucolipotoxicity or tunicamycin exhibited increased ROS generation, gene and protein
(PERK, GRP-78, IRE1α, and CHOP) expression of ER stress markers. In addition, these cells showed increased TRPC-6 channel
expression and apoptosis as revealed by DNA damage and increased caspase-3 activity. While glucolipotoxicity/tunicamycin
increased oxidative stress, ER stress, mRNA expression of TRPC-6, and programmed the THP-1 monocytes towards apoptosis,
all these molecular perturbations were resisted by PBA. Since ER stress is one of the underlying causes of monocyte dysfunction
in diabetes and atherosclerosis, our study emphasize that chemical chaperones such as PBA could alleviate ER stress and have
potential to become novel therapeutics.
1. Introduction
Cardiovascular complications due to atherosclerotic disease
are a frequent cause of morbidity and mortality in patients
with diabetes [1]. A role for immune cells such as monocytes
and lymphocytes has been implicated in the pathogenesis of
diabetes and its various complications including atheroscle-
rosis. Clinical and experimental evidence indicates that
inflammatory processes in the vascular wall are the decisive
factor that accounts for the rate of lesion formation and
clinical development in patients suffering from atheroscle-
rosis [2]. Monocytes and macrophages, in an attempt to
engulf lipid laden cells along the blood vessel, will get
exposed to hyperglycemia and hyperlipidemia, a combined
pathophysiological situation referred to as “glucolipotox-
icity.” The exact mechanisms by which glucolipotoxicity
triggers monocyte activation and atherosclerotic processes
are not clearly understood. However, evidence indicates that
ER stress plays an important role in these mechanisms.
ER stress is known to activate a series of signals that
comprise the unfolded protein response (UPR). The UPR
includes at least three signaling pathways initiated by the
kinases IRE1 and PERK and the transcription factor ATF6
[3] signals that coordinate the cellular response to unfolded
proteins, which includes (a) downregulation of protein
translation, (b) enhanced expression of ER chaperone pro-
teins that promote protein refolding, and (c) activation of
proteases involved in the degradation of misfolded proteins.
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Conversely, prolonged or severe ER stress can lead to the acti-
vation of apoptotic cell death. Recent studies have suggested
that chronic ER stress originating from glucolipotoxicity is
one of the major culprits that can very well explain the
underlying causes of both insulin resistance and β-cell dys-
function [4–7]. ER stress has been linked to insulin resistance
in diabetes and also expansion of ER was detected in β-cells
from type 2 diabetic patients [8, 9]. Furthermore, increased
expression of ER stress markers has been demonstrated in
db/db mouse islets and β-cells of type 2 diabetes patients
[9, 10]. Recent studies also imply that β-cell dysfunction by
glucolipotoxicity-induced ER stress is mediated by increased
oxidative stress and apoptosis [11]. While the recruitment
of monocytes and their retention within atherosclerotic
lesions contribute to plaque development [12], macrophage
apoptosis within advanced atherosclerotic lesions is also
known to increase the risk of atherothrombotic disease
[13]. Although glucolipotoxicity is known to trigger ER
stress, its effect on various arms of the ER stress machinery
in monocytes has not been clearly defined. Therefore, we
investigated the effect of glucolipotoxicity on monocytes
with reference to ROS generation, transcriptional alterations
of various ER stress markers, and apoptotic indicators. We
also investigated the effect of 4-phenyl butyric acid (PBA,
a chemical chaperone) whether it resists glucolipotoxicity-
induced ER stress and apoptosis.
2. Materials and Methods
2.1. Cell Culture and Treatment. The humanmonocyte THP-
1 cells were obtained from the National Centre for Cell
Science (NCCS, Pune, India). THP-1 cells were maintained
in endotoxin-free RPMI-1640 containing 5.5mM glucose,
10% (v/v) heat-inactivated fetal bovine serum, 100U/mL
penicillin, 100 μg/mL streptomycin, 2.5 μg/L amphotericin
B, 2mM L-glutamine, 1mM sodium pyruvate and 10mM
HEPES, pH 7.0–7.4, under a humidified condition of 5%
CO2 at 37◦C. For all the experiments, cells were subjected
to either 5.5mM glucose (basal) or glucolipotoxicity (25mM
glucose plus 0.5mM palmitic acid) or tunicamycin (4 μM)
treatment for 24 h in the presence and absence of 4-
PBA (1mM), in serum-free medium. All experiments were
independently performed at least thrice.
2.2. Intracellular Reactive Oxygen Species (ROS) Measure-
ment. Intracellular ROS generation was measured in THP-
1 monocytes as described earlier [14] with minor modi-
fications as to the confocal application. Briefly, 1 × 103
cells were seeded in confocal chambered slides (LabTek II)
precoated with 0.01% poly-L-lysine. After the treatment
conditions, 2′,7′-dichlorodihydrofluorescein diacetate (H2-
DCFDA, 10 μM) dye was added to each well and incubated
for 30min at 37◦C. Cells were then washed twice with PBS.
To capture the change in fluorescence, cells were excited at a
wavelength of 485 nm and the fluorescence emission was read
at 530 nm using Carl Zeiss-LSM 700 confocal microscope
with an objective of 20x. Change in mean fluorescence
intensity was represented as arbitrary units (AU).
2.3. Real-Time PCR
2.3.1. RNA Isolation. Total RNA from cells was isolated
as described previously [15]. The RNA quality and con-
centration of total RNA were measured using nanodrop.
1 μg of RNA was converted to cDNA using 100 units
reverse transcriptase enzyme, 40 μM Oligo-dT18 primer
(New England Biolabs), 10xRT buffer, 20U RNase inhibitor
(Amersham Biosciences), and 2.5mM each of dNTPS and
incubated at 42◦C for 1 h.
2.3.2. Quantitative Real-Time PCR. Quantitative real-time
PCR was performed for specific genes using SYBR green
master mix (Finnzymes). PCR amplification was carried out
using ABI-7000 (Applied Biosystems) with cycle conditions
(initial cycle: 50◦C for 2min, Initial denaturation 95◦C
for 15 sec, 40 cycles of denaturation 95◦C for 15 sec, and
annealing/extension of 60◦C for 1min). The expression level
of RNA was determined using 2−DDCt and normalized using
β-actin. The primer sequences of specific genes are listed in
Table 1.
2.4. Protein Expression. After specific treatments, cells were
lysed using RIPA buffer (50mM Tris-HCl (pH 8.0), 150mM
NaCl, 0.1% SDS, 0.2% sodium azide, 1% Triton X-100,
0.25% sodium deoxycholate, and 1x protease inhibitor). In
brief, cells were sonicated and incubated for 1 hr in ice and
centrifuged at 16,000 g for 5 minutes at 4◦C. The supernatant
collected was quantified for protein by Bradford method.
15 μg protein was resolved on a 10% SDS-PAGE and trans-
ferred to polyvinylidine fluoride (PVDF) membrane. After 1
hour blocking in 5% bovine serum albumin (BSA) and incu-
bation with the appropriate primary antibodies and HRP-
conjugated secondary antibodies, detection was performed
using enhanced chemiluminescence kit (GE Healthcare). β-
actin was used as internal control. Mean densitometry data
from independent experiments were normalized to control
using Image-J software and represented as the ratio of test
protein and β-actin.
2.5. DNA Damage—Comet Assay. DNA damage was eval-
uated with the Comet assay as described previously [16].
Briefly, the treated cells were mixed with 200 μL of 0.5%
low-melting point agarose and layered over clear microscope
slides precoated with 1% normal melting agarose. Lysis,
electrophoresis, and neutralization were followed by staining
with ethidium bromide. The slides were examined under a
fluorescent microscope. They were scored using an image
analysis system (Comet Imager 1.2.13) attached to a flu-
orescent microscope (Carl-Zeiss, Germany) equipped with
appropriate filter.
2.6. Caspase 3 Activity Assay. Caspase-3 activity was deter-
mined by colorimetric assay using the caspase-specific
peptide containing amino acid sequence Asp-Glu-Val-Asp
(DEVD) that is conjugated to the color reporter molecule
p-nitroanilide (pNA) (RandD systems). The cleavage of the
peptide by the caspases releases the chromophore pNA,
Experimental Diabetes Research 3
Table 1: Primer sequence of specific genes.
GRP78
Forward CTG CCA TGG TTC TCA CTA AAA TG
Reverse TTA GGC CAG CAA TAG TTC CAG
PERK
Forward GAA CCA GAC GAT GAG ACA GAG
Reverse GGA TGA CAC CAA GGA ACC G
IRE1
Forward GCG AAC AGA ATA CAC CAT CAC
Reverse ACC AGC CCA TCA CCA TTG
XBP1
Forward TGG ATT CTG GCG GTA TTG AC
Reverse TCC TTC TGG GTA GAC CTCTG
ATF-6
Forward CCT GTC CTA CAA AGT ACC ATG AG
Reverse CCT TTA ATC TCG CCT CTA ACC C
CHOP/GADD
Forward GTA CCT ATG TTT CAC CTC CTG G
Reverse TGG AAT CTG GAG AGT GAG GG
TRPC6
Forward TTT GAG GAG GGC AGA ACA CTT
CCT
Reverse TAT GGC CCT GGA ACA GCT CAG AAA
β-actin
Forward GTC TTC CCC TCC ATC GT
Reverse CGT CGC CCA CAT AGG AAT
which is quantified spectrophotometrically at 405 nm. Cells
harvested after treatment were lysed and 10 μg protein was
aliquoted from each sample into a 96 well plate. 0.5 μL DTT
was added to all the wells followed by addition of 50 μL
of 2x reaction buffer and 3.5 μL of Caspase-3 colorimetric
substrate. The plate was incubated at 37◦C for 1 hr and read
at 405 nm using microplate reader. Caspase-3 activity was
expressed as mean ± SEM of optical density.
2.7. Statistical Analysis. Statistical Package for Social Sciences
(SPSS) Windows, (Version 16.0, Chicago, IL), was used for
statistical analysis. Data were expressed as Mean ± SEM.
Comparisons between groups were performed using stu-
dent’s t-test and a P-value < 0.05 was considered statistically
significant.
3. Results
We have applied confocal microscopy to measure the flu-
orescent intensity of DCF which indicates the extent of
intracellular ROS generation in monocytes. While represen-
tative fluorescent images related to ROS generation were
depicted in Figure 1(a), cumulative data on ROS generation
were presented in Figure 1(b). Cells subjected to either
glucolipotoxicity or tunicamycin exhibited increased ROS
generation compared to the untreated cells (Figure 1(b)).
Pretreatment of cells with 4-phenyl butyric acid showed
significant reduction in ROS generation (P < 0.05). A
complete mRNA expression pattern of ER stress machinery
was determined by real-time PCR and the cumulative data
on mRNA pattern of ER stress markers in relation to their
ratio with the house keeping β-actin was depicted in Figure 2.
Compared to untreated cells, cells treated with glucolipotox-
icity or tunicamycin showed an increased mRNA expression
of PERK, GRP78, IRE1α, XBP1, ATF6, and CHOP (Figures
2(a)–2(f)). It is also interesting to note that the extent
increase in ER stress markers under glucolipotoxicity was
higher than that induced by tunicamycin. PBA treatment
significantly reduced all the transcriptional expression of
ER stress markers most likely due to its chaperone activity.
Figure 3(A) depicts the representative protein expression of
ER stress markers along with β-actin. Consistent with the
mRNA results, protein expression of ER stress markers,
namely, PERK, GRP78, IRE1α, and XBP1 were also increased
in cells subjected to glucolipotoxicity and tunicamycin treat-
ment (Figure 3(B)). 4-PBA treatment significantly reduced
the protein expression of all the ER stress markers.
Since the programming of apoptosis by both the oxida-
tive and ER stress signals depend on the load of intracellular
Ca2+, we investigated the transcriptional level of TRPC-
6, which is an important driving force for increased Ca2+
influx. Cells treated with glucolipotoxicity or tunicamycin
resulted in several folds of increase in TRPC-6 mRNA levels
(Figure 4) and this was significantly normalized by PBA.
Compared to untreated cells, cells treated with glucolipo-
toxicity or tunicamycin showed increased DNA damage (4.6
and 3 folds, resp.). Interestingly, PBA treatment significantly
reduced the DNA damage induced either by glucolipotoxicity
or tunicamycin (Figure 5(a)). Since CHOP (an intermediate
in caspase-dependent apoptosis) mRNA and protein expres-
sion were increased in cells subjected to glucolipotoxicity or
tunicamycin, we estimated the activity of caspase-3 enzyme.
As expected, cells treated with glucolipotoxicity or tuni-
camycin showed significantly increased caspase-3 activity
(Figure 5(b)) implying that uncontrolled ER stress might
have programmed the cells towards apoptosis. Increased
caspase-3 activity either due to glucolipotoxicity or tuni-
camycin was significantly (P < 0.05) reduced by 4-PBA.
4. Discussion
The following are the nutshell findings of the study. First,
monocytes subjected to glucolipotoxicity showed increased
ROS generation and increased mRNA expression of several
genes of the ER stress machinery. Secondly, these monocytes
exhibited features of chronic ER stress as evidenced by
increased mRNA expression of TRPC-6, DNA damage, and
caspase-3 activity. Thirdly, PBA—a chemical chaperone,
resisted all the glucolipotoxicity-induced cellular and molec-
ular alterations in monocytes emphasizing the benefits of ER
stress alleviation.
Monocyte activation, adhesion to the endothelium,
and transmigration into the subendothelial space are
key events in early pathogenesis of atherosclerosis. The
mechanisms by which glucose and lipid toxicity induces
monocyte-associated atherosclerosis are only partially
known. Mononuclear blood cells from patients with diabetes
show increased generation of reactive oxygen species and
altered redox signaling [16–21]. In our study, monocytes
subjected to glucolipotoxicity exhibited increased generation
of ROS. ROS could activate cell death processes directly
by the oxidation of proteins, lipids, and/or nucleic acids
or could act as initiators or second messengers in the cell
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Figure 1: (a) Representative confocal microscopy images of Intracellular ROS generation in cells treated under various conditions. (b) Mean
(±SEM) fluorescence intensities of ROS under different experimental maneuvers, namely, control, glucolipotoxicity (GLT), glucolipotoxicity
+ 4-phenyl butyric acid (GLT + PBA), tunicamycin (Tun), tunicamycin + 4-phenyl butyric acid (Tun + PBA), 4-phenyl butyric acid (PBA).
∗P < 0.05 compared to control, #P < 0.05 compared to GLT, ∗∗P < 0.05 compared to tunicamycin.
death process. Accumulating evidence suggests that protein
folding and generation of reactive oxygen species (ROS)
as a byproduct of protein oxidation in the ER are closely
linked events. It has also become apparent that activation
of the UPR on exposure to oxidative stress is an adaptive
mechanism to preserve cell function and survival. However,
persistent oxidative stress and protein misfolding initiate
apoptotic cascades and are now known to play predominant
roles in the pathogenesis of multiple human diseases
including diabetes and atherosclerosis [22–24].
A number of hypotheses have been conceived to explain
advanced lesional macrophage apoptosis and atherosclerosis,
and undoubtedly more than one mechanism is involved.
Recent mechanistic data in cultured cells and correlative
and genetic causation evidence in vivo support a role for
endoplasmic reticulum (ER) stress in advanced lesional
macrophage apoptosis and its major consequence of plaque
necrosis [13, 25]. Consistent with previous findings, glucol-
ipotoxicity in our study showed increased transcription of
PERK, GRP78, IRE1α, XBP-1, ATF6, and CHOP in mono-
cytes. This was also corroborated by the increased protein
expression of ER stress markers. The fact that increased
expression of ER stress markers under glucolipotoxicity is
similar to that induced by tunicamycin (a known inducer of
ER stress) emphasizes that glucolipotoxicity inducts ER stress
in monocytes.
Increased TRPC-6 mRNA expression under glucolipo-
toxicity in our study implies a role for increased calcium
levels in monocyte dysfunction and ER stress. Calcium is an
essential intracellular messenger and serves critical cellular
functions in both excitable and nonexcitable cells. Available
data on transient receptor potential conical (TRPC) protein
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Figure 2: Relative gene expression Mean (±SEM) data of ER stress markers namely, PERK (a), GRP78 (b), IRE1α (c), XBP-1 (d), ATF6 (e),
CHOP (f). ∗P < 0.05 compared to control, #P < 0.05 compared to GLT, ∗∗P < 0.05 compared to tunicamycin.
indicate that these proteins initiate Ca2+ entry pathways and
are essential in maintaining cytosolic, ER, andmitochondrial
Ca2+ levels [26]. Alterations in Ca2+ homeostasis have been
suggested in diabetes and associated complications [27, 28].
Zhu et al. [28] have recently reviewed a role for TRP channels
and their implications in metabolic diseases. Activity of
TRPC is physiologically important as Ca2+ concentrations
within the ERmust be maintained at sufficient levels in order
for the organelle to carry out many of its fundamental func-
tions including protein folding and trafficking. However, loss
of Ca2+ homeostasis due to improper TRPC activation could
lead to ER stress responses, and even apoptosis [29]. While
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Figure 3: (A) Representative protein expression data on ER stress protein markers, namely, PERK (1), GRP78 (2), IRE1α (3), and CHOP
(4). (B) Cumulative histogram data Mean (±SEM) of ER stress markers, namely, PERK (a), GRP78 (b), IRE1α (c) and CHOP (d). ∗P < 0.05
compared to control, #P < 0.05 compared to GLT, ∗∗P < 0.05 compared to tunicamycin.
oxidative stress could result in cellular defects including a
defect in ER Ca2+ uptake and Ca2+ efflux, thereby increasing
[Ca2+]i and Ca2+ influx [30], several TRPC families have also
been shown directly activated in response to oxidative stress
[31]. In our study, both glucolipotoxicity and tunicamycin
resulted in increased ROS generation in monocytes and, at
the transcription level, we have also witnessed the increased
TRPC6 mRNA expression. Among the TRPC subfamily
of TRP channels, TRPC6 is gated by signal transduction
pathways that activate C-type phospholipases as well as
by direct exposure to diacylglycerols [32]. Recent studies
emphasize a pathophysiological role of TRPC6 in several
disease states [33, 34] and it appears to be an emerging drug
target. Altered TRPC6 regulation and impaired capacitative
calcium entry have been shown in vessels of diabetic patients
[35]. While a role for oxidative stress has been implicated
in the pathogenesis of Type 2 diabetes and its micro- and
macrovascular complications [20], TRPC6 mRNA was also
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Figure 4: Mean (±SEM) mRNA expression of TRPC-6. ∗P < 0.05 compared to control, #P < 0.05 compared to GLT, ∗∗P < 0.05 compared
to tunicamycin.
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Figure 5: (a) Mean (±SEM) percentage DNA damage under different experimental conditions. ∗P < 0.05 compared to control, #P < 0.05
compared to GLT, ∗∗P < 0.05 compared to tunicamycin. (b) Mean (±SEM) Caspase 3 activity under different experimental conditions.
∗P < 0.05 compared to control, #P < 0.05 compared to GLT, ∗∗P < 0.05 compared to tunicamycin.
shown significantly higher in monocytes from patients with
type 2 diabetes [36] pointing to a novel pathway for increased
activation of monocytes and hence atherosclerosis in patients
with diabetes.
ER stress is one of the damaging stresses resulting from
glucolipotoxicity which can lead to apoptosis when the stress
is prolonged or uncontrolled. Komura et al. [37] have shown
that monocytes of diabetic patients are not as efficient in
phagocytosing as in normal healthy people and electron
microscopic examination of monocytes revealed morpho-
logic alterations in the ER of cells derived from patients
with diabetes. Although it has been known that activation
of the CHOP pathway of the UPR can cause apoptosis, the
molecular mechanisms linking CHOP to death execution
pathways is poorly understood. Our results here show that
apoptosis might be executed by the increased activation
of caspase-3 under glucolipotoxicity. Since autophagy has
been proposed to operate as an alternative cell death
mechanism or act upstream of apoptosis [38], it is plausible
that glucolipotoxicity-induced ER stress could also promote
cell death via autophagy [39, 40]. ER stress-induced UPR
activation can also influence the expression of certain inflam-
matory cytokines [41] rendering the monocyte intrinsically
proinflammatory which might have drastic consequences
when monocytes infiltrate the intima of the vessel wall.
Recent work has provided evidence for a calcium dependent
mechanism in ER stress-inducedmacrophage apoptosis [42].
The increased mRNA levels of TRPC-6 seen in our study also
support this. Since caspase and the downstream apoptosis
effector molecules are Ca2+-dependent, future studies should
also focus on the involvement of intracellular calcium in the
induction of apoptosis in ER-stressed cells under glucose and
lipid dyshomeostasis.
In our study, glucolipotoxicity-induced ROS generation
and increased ER stress markers seen under glucolipotoxicity
were normalized by PBA. Drugs that interfere with ER
stress have wide therapeutic potential and recently chemical
chaperones like tauroursodeoxycholic acid (TUDCA), and
PBA received much attention because of their ER stress
alleviating activities as these compounds improve ER folding
capacity and help in stabilizing protein conformation [43].
PBA was found to be protective in in vitro and in vivomodels
of diabetes [43–45]. Accumulating evidence suggests that
protein folding and generation of reactive oxygen species
(ROS) as a byproduct of protein oxidation in the ER are
closely linked events. While facilitating appropriate protein
folding, PBA helps maintaining the balance between ER
oxidoreductin 1 (ERO1) and protein disulfide isomerase
(PDI) and thereby reduces the ROS levels generated during
protein oxidation [46]. It has also been shown that PBA
counteracts oxidative stress by upregulating the expression
and activity of superoxide dismutase (SOD) [47, 48]. Luo
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et al. [49] have also demonstrated PBA inhibition of NADPH
oxidase activity and emphasized a dual regulation ER stress
and oxidative stress by PBA. Erbay et al. [50] demonstrated
that mitigation of ER stress with PBA protectedmacrophages
against lipotoxic death and atherosclerosis by suppression of
XBP1 splicing and CHOP expression. PBA has been shown to
regulate ER stress and offer potential therapeutic benefits in
several preclinical models of human diseases including type
2 diabetes [43, 51–55]. As an orally bioavailable terminal
aromatic substituted fatty acid, PBA has been used for the
treatment of urea cycle disorders [56]. More importantly,
oral treatment of PBA was recently shown preventing lipid-
induced impairment in insulin sensitivity and b-cell function
in humans [57].
To conclude, our study exposes the convergence of ER
stress, oxidative stress and apoptosis in the presence of glu-
colipotoxicity inmonocytes and points out ER stress network
as a novel drug-targetable pathway. Our results also empha-
size that chemical chaperones enhance the adaptive capacity
of the ER, and on further evaluation in appropriate clinical
trials, could serve as potent antidiabetic/antiatherosclerotic
modalities with potential application in the treatment of type
2 diabetes and its vascular complications like atherosclerosis.
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